香港科技探索(01137.HK)股價異動 未知悉原因
格隆匯4月16日丨香港科技探索(01137.HK)公吿,董事會得悉,公司股份的價格及成交量均於今日有所上升。
經作出於相關情況下有關公司合理查詢後,董事會確認並不知悉任何導致該等股價及成交量變動原因,或任何必須公佈以避免公司證券出現虛假市場資料或任何須根據香港法例第571章證券及期貨條例第XIVA部予以披露內幕消息。董事會確認並無任何有關股份交易的討論、商談或協議。
此外,公司已向其主要股東-Top Group International Limited進行查詢,彼已確認並無意或計劃於未來兩年內以任何價格出售其所持有的公司股份。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.